Geode Capital Management
CLOV icon

Geode Capital Management’s Clover Health Investments CLOV Stock Holding History

Geode Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47.9M Buy
11,115,990
+269,924
+2% +$1.21M ﹤0.01% 1612
2026
Q2 		$56.8M Buy
10,846,066
+790,556
+8% +$2.68M ﹤0.01% 1555
2026
Q1 		$17.7M Buy
10,055,510
+264,302
+3% +$573K ﹤0.01% 2061
2025
Q4 		$23M Buy
9,791,208
+70,801
+0.7% +$194K ﹤0.01% 1927
2025
Q3 		$29.7M Sell
9,720,407
-122,942
-1% -$351K ﹤0.01% 1795
2025
Q2 		$27.5M Buy
9,843,349
+4,812,368
+96% +$15.8M ﹤0.01% 1793
2025
Q1 		$18.1M Buy
5,030,981
+148,520
+3% +$596K ﹤0.01% 1951
2024
Q4 		$15.4M Buy
4,882,461
+53,760
+1% +$192K ﹤0.01% 2102
2024
Q3 		$13.6M Buy
4,828,701
+868,501
+22% +$1.99M ﹤0.01% 2190
2024
Q2 		$4.87M Sell
3,960,200
-341,358
-8% -$306K ﹤0.01% 2738
2024
Q1 		$3.42M Buy
4,301,558
+40,815
+1% +$37.1K ﹤0.01% 2889
2023
Q4 		$4.06M Buy
4,260,743
+190,837
+5% +$187K ﹤0.01% 2813
2023
Q3 		$4.4M Buy
4,069,906
+420,083
+12% +$500K ﹤0.01% 2708
2023
Q2 		$3.27M Sell
3,649,823
-3,255,478
-47% -$2.89M ﹤0.01% 2919
2023
Q1 		$5.84M Buy
6,905,301
+287,443
+4% +$315K ﹤0.01% 2567
2022
Q4 		$6.15M Buy
6,617,858
+355,933
+6% +$475K ﹤0.01% 2550
2022
Q3 		$10.6M Buy
6,261,925
+238,217
+4% +$624K ﹤0.01% 2201
2022
Q2 		$12.9M Buy
6,023,708
+3,648,769
+154% +$9.7M ﹤0.01% 2077
2022
Q1 		$8.43M Sell
2,374,939
-28,900
-1% -$83.8K ﹤0.01% 2466
2021
Q4 		$8.94M Buy
2,403,839
+614,777
+34% +$3.77M ﹤0.01% 2526
2021
Q3 		$13.2M Buy
1,789,062
+775,633
+77% +$6.64M ﹤0.01% 2260
2021
Q2 		$13.5M Buy
1,013,429
+44,832
+5% +$440K ﹤0.01% 2250
2021
Q1 		$7.32M Buy
+968,597
New +$10.9M ﹤0.01% 2573

Other funds holding CLOV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management's CLOV Position: Q3 2026 in Review

Geode Capital Management increased its Clover Health Investments (CLOV) stake by 2.5% in Q3 2026, buying an estimated $1.21M and bringing the position to 11,115,990 shares worth $47.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Geode Capital Management first reported a position in CLOV in Q1 2021 and has held it in 23 quarters since. The position peaked at $56.8M in Q2 2026. 176 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • Geode Capital Management held 11,115,990 shares of Clover Health Investments worth $47.9M as of Q3 2026.
  • Geode Capital Management bought 269,924 Clover Health Investments shares in Q3 2026, an estimated $1.21M.
  • Clover Health Investments made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #1612 holding.
  • Geode Capital Management first reported a position in Clover Health Investments in Q1 2021 and has held it in 23 quarters since.
  • Geode Capital Management's Clover Health Investments position peaked at $56.8M in Q2 2026.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.